Skip to Content

Latest Research: The Vaping Crisis

March 2, 2020
Acute lung injury due to vaping remains a primary concern. The physicians and researchers in the Division of Pulmonary, Allergy and Critical Care Medicine (PACCM) continue to explore cause, effects, and treatment options for patients affected by the use of e-cigarettes and other vaping devices. Two case series of our experiences with these patients have been published, and the data show 75 percent were treated with corticosteroids, and almost 10 percent were readmitted to the hospital after their initial presentation. About half of the patients returned for follow-up, and investigation of the impact on long-term pulmonary function is ongoing.

Clinical Characterization of E-cigarette, or Vaping, Product Use Associated Lung Injury in 36 Patients in Pittsburgh, PA
American Journal of Respiratory and Critical Care Medicine 

Richard H Zou, Perry J Tiberio, Georgios A Triantafyllou, Phillip E Lamberty, Michael J Lynch, John W Kreit, Bryan J. McVerry, Mark T Gladwin, Alison Morris, Jared Chiarchiaro, Meghan E. Fitzpatrick, and Jason J Rose

Published Online: February 05, 2020

PMID: 32023422
DOI: 10.1164/rccm.202001-0079LE

Vaping-associated Acute Lung Injury: A Case Series
American Journal of Respiratory and Critical Care Medicine

Georgios A. Triantafyllou, Perry J. Tiberio, Richard H. Zou, Phillip E. Lamberty, Michael J. Lynch, John W. Kreit, Mark T. Gladwin, Alison Morris, Jared Chiarchiaro

Published: December 1, 2019

PMID: 31574235
DOI: 10.1164/rccm.201909-1809LE